These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9569035

  • 21. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P, Illana FJ, Martín-Morales L, de la Hoya M, Garre P, Ibañez-Royo MD, Pérez-Segura P, Caldés T, García-Barberán V.
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [Abstract] [Full Text] [Related]

  • 22. High frequency of germline p53 mutations in childhood adrenocortical cancer.
    Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D.
    J Natl Cancer Inst; 1994 Nov 16; 86(22):1707-10. PubMed ID: 7966399
    [Abstract] [Full Text] [Related]

  • 23. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G.
    Oncogene; 1994 Nov 16; 9(11):3273-80. PubMed ID: 7936651
    [Abstract] [Full Text] [Related]

  • 24. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla.
    Patrikidou A, Bennett J, Abou-Sleiman P, Delhanty JD, Harris M.
    Oral Oncol; 2002 Jun 16; 38(4):383-90. PubMed ID: 12076704
    [Abstract] [Full Text] [Related]

  • 25. A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome.
    Dockhorn-Dworniczak B, Wolff J, Poremba C, Schäfer KL, Ritter J, Gullotta F, Jürgens H, Böcker W.
    Eur J Cancer; 1996 Jul 16; 32A(8):1359-65. PubMed ID: 8869100
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
    Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, Evans DG, Harris M, Kelsey AM, Birch JM.
    Am J Hum Genet; 1999 Oct 16; 65(4):995-1006. PubMed ID: 10486318
    [Abstract] [Full Text] [Related]

  • 28. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
    Stein T, Crighton D, Boyle JM, Varley JM, White RJ.
    Oncogene; 2002 May 02; 21(19):2961-70. PubMed ID: 12082526
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S, Verselis S, Portwine C, Garber J, White M, Feunteun J, Malkin D, Li FP.
    Oncogene; 1999 Jul 08; 18(27):3970-8. PubMed ID: 10435620
    [Abstract] [Full Text] [Related]

  • 31. Three germline mutations in the TP53 gene.
    Cornelis RS, van Vliet M, van de Vijver MJ, Vasen HF, Voute PA, Top B, Khan PM, Devilee P, Cornelisse CJ.
    Hum Mutat; 1997 Jul 08; 9(2):157-63. PubMed ID: 9067756
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K, Fong C, Buzin C, Sommer SS, Saldivar JS.
    Curr Protoc Hum Genet; 2008 Apr 08; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [Abstract] [Full Text] [Related]

  • 34. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
    Trková M, Sedlácek Z.
    Cas Lek Cesk; 2003 Apr 08; 142(4):220-5. PubMed ID: 12841124
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
    Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KJ, Evans DG, Birch JM.
    Oncogene; 1997 Feb 20; 14(7):865-71. PubMed ID: 9047394
    [Abstract] [Full Text] [Related]

  • 37. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM.
    Cancer Res; 1997 Aug 01; 57(15):3245-52. PubMed ID: 9242456
    [Abstract] [Full Text] [Related]

  • 38. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I, Mohr N, Kramer F, Weber BH.
    Cancer Genet Cytogenet; 2004 Oct 01; 154(1):22-6. PubMed ID: 15381368
    [Abstract] [Full Text] [Related]

  • 39. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.
    Krutilkova V, Trkova M, Fleitz J, Gregor V, Novotna K, Krepelova A, Sumerauer D, Kodet R, Siruckova S, Plevova P, Bendova S, Hedvicakova P, Foreman NK, Sedlacek Z.
    Eur J Cancer; 2005 Jul 01; 41(11):1597-603. PubMed ID: 15925506
    [Abstract] [Full Text] [Related]

  • 40. Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes.
    Moore SK, Zambrano N, Lynch HT, Lipkin M, Kopelovich L.
    Cancer Genet Cytogenet; 1996 Sep 01; 90(2):125-9. PubMed ID: 8830720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.